Hi Yann! Great to hear! We are definitely planning to implement both but neither I nor @Robert Forsyth didnt have a lot of time yet to do this. Regarding Savannah, we see a lot of germline bleed through in tumour-only mode. But we definitely want it to be an option for people to use. We would welcome any help with implementing either (or both) of them. The main requirement we would have is that they are compatible with CHM13 reference genome.